How Dual U.S. and China Trial Approvals for SYH2070 Could Shape CSPC (SEHK:1093) Investors' Outlook

The Board of Directors of CSPC Pharmaceutical Group recently announced that its novel SYH2070 siRNA injection received regulatory approval to begin clinical trials in both the U.S. and China for the ...

Cracking a mystery: Threat mails in Mumbai, Delhi, clues in Chennai

Investigators have traced several “commonalities” in all these mails, such as conspiracy theories about South Indian ...